Minerva Neurosciences, Inc (NERV) financial statements (2022 and earlier)

Company profile

Business Address 1601 TRAPELO ROAD
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments60,75525,35745,85487,997128,16182,98132,205
Cash and cash equivalents60,75525,35721,41350,23526,05282,98114,284
Short-term investments  24,44237,762102,109 17,921
Restricted cash and investments100100100100808080
Prepaid expense1,3461,9831,1821,9211,2998031,196
Total current assets:62,20127,44047,13790,018129,54083,86433,481
Noncurrent Assets
Operating lease, right-of-use asset 102262
Property, plant and equipment  1633511026
Long-term investments and receivables    5,023  
Long-term investments    5,023  
Intangible assets, net (including goodwill)14,86930,06930,06949,06949,06949,06949,069
Goodwill14,86914,86914,86914,86914,86914,86914,869
Intangible assets, net (excluding goodwill) 15,20015,20034,20034,20034,20034,200
Other noncurrent assets 15151515  
Other undisclosed noncurrent assets51      
Total noncurrent assets:14,92030,18630,36249,11854,15849,07949,096
TOTAL ASSETS:77,12257,62677,499139,136183,699132,94382,576
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9161,1372,6312,2551,7131,7102,144
Accounts payable1,8539962,3171,8001,4361,4681,361
Accrued liabilities63141314456251192 
Employee-related liabilities    6 725
Interest and dividends payable    215059
Debt  173 3,9634,8541,435
Other undisclosed current liabilities9032,0243,8251,3541,1623,1221,741
Total current liabilities:2,8193,1606,6293,6096,8389,6865,320
Noncurrent Liabilities
Long-term debt and lease obligation  111  3,8418,503
Long-term debt, excluding current maturities     3,8418,503
Operating lease, liability  111
Liabilities, other than long-term debt 1,80342,97941,20545,26313,43413,434
Deferred revenue and credits41,176  
Deferred revenue  41,176
Contract with customer, liability41,176
Deferred tax liabilities, net 4,05713,43413,434
Deferred income tax liabilities 1,8031,803
Other liabilities   2930  
Other undisclosed noncurrent liabilities66,327  4,057   
Total noncurrent liabilities:66,3271,80343,09045,26245,26317,27521,937
Total liabilities:69,1464,96449,71948,87152,10126,96127,257
Stockholders' equity
Stockholders' equity attributable to parent7,97652,66327,78090,265131,597105,98255,320
Common stock4444442
Additional paid in capital342,673337,454314,512304,814295,975238,837157,130
Accumulated deficit(334,701)(284,795)(286,736)(214,553)(164,381)(132,858)(101,813)
Total stockholders' equity:7,97652,66327,78090,265131,597105,98255,320
TOTAL LIABILITIES AND EQUITY:77,12257,62677,499139,136183,699132,94382,576

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 41,176     
Gross profit: 41,176     
Operating expenses(45,366)(39,329)(75,865)(51,730)(41,170)(30,191)(26,110)
Operating income (loss):(45,366)1,847(75,865)(51,730)(41,170)(30,191)(26,110)
Nonoperating income (expense)(16)941,4271,66988517581
Investment income, nonoperating171611,4561,67494219897
Foreign currency transaction loss, before tax(33)(67)(29)(5)(57)(23)(16)
Income (loss) from continuing operations before equity method investments, income taxes:(45,382)1,941(74,438)(50,061)(40,285)(30,016)(26,029)
Other undisclosed loss from continuing operations before income taxes(6,327)  (110)(614)  
Income (loss) from continuing operations before income taxes:(51,709)1,941(74,438)(50,171)(40,899)(30,016)(26,029)
Income tax benefit1,803 2,254 9,376  
Net income (loss):(49,906)1,941(72,183)(50,171)(31,523)(30,016)(26,029)
Other undisclosed net loss attributable to parent     (1,030)(1,053)
Net income (loss) available to common stockholders, diluted:(49,906)1,941(72,183)(50,171)(31,523)(31,045)(27,082)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(49,906)1,941(72,183)(50,171)(31,523)(30,016)(26,029)
Comprehensive income (loss), net of tax, attributable to parent:(49,906)1,941(72,183)(50,171)(31,523)(30,016)(26,029)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: